Taro Pharmaceuticals recalls
Taro Pharmaceuticals appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2023-11-15.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 4 |
|---|---|
| Published | 2015-09-02 to 2023-11-15 |
| By agency | FDA Drug (4) |
| By classification | Class II (2), Class III (2) |
| By status | terminated (4) |
| Distribution named in notices | PR, US |
Recalls
- Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc
FDA Drug · Class III · 2023-11-15 · Taro Pharmaceuticals
Reason: Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing. - Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc
FDA Drug · Class II · 2016-11-09 · Taro Pharmaceuticals
Reason: Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation). - Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc
FDA Drug · Class II · 2016-11-09 · Taro Pharmaceuticals
Reason: Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation). - Topicort (desoximetasone) Topical Spray, 0.25%, 100 mL Bottles, Rx Only
FDA Drug · Class III · 2015-09-02 · Taro Pharmaceuticals
Reason: Failed Impurities/Degradation Specifications: Out of specification results for impurities testing was obtained at the 6 and 9 month time points.